Waters Corp., a Milford-headquartered laboratory instrument and software company with 7,500 employees worldwide, has expanded its board of directors with the addition of Dan Brennan and Mark Vergnano.
Brennan is executive vice president and CFO of Boston Scientific Corp., a global medical device company headquartered in Marlborough.
Vergnano is the former chairman, president, and CEO of The Chemours Company, a Delaware chemistry company spun off from DuPont de Nemours, Inc., and is a partner at Sea Shell Partners LLC, also in Delaware.
Brennan and Vergnano’s selection to the board was first announced by the company on Nov. 23.
The appointments of Brennan and Vergnano expands Waters’ board to nine members, including eight independent members and President and CEO Udit Batra. Five of the company’s board members have been appointed in the last five years.
Waters Corp., which has $2.7 billion in annual revenue, is publicly traded on the New York Stock Exchange. It has 1,600 employees based in Central Massachusetts.
